Nephron Pharmaceuticals

FDA Filings

This page includes the latest FDA filings for Nephron Pharmaceuticals. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
NEPHRON PHARMACEUTICALS
 Sodium Chloride Inhalation Solution, USP 0.9% 0487-9302-012024-03-07
NEPHRON PHARMACEUTICALS
 Sodium Chloride Inhalation Solution, USP 0.9% 0487-9301-332024-03-07
NEPHRON PHARMACEUTICALS
 Sodium Chloride Inhalation Solution, USP 0.9% 0487-9301-032024-03-07
NEPHRON PHARMACEUTICALS
 Sodium Chloride Inhalation Solution, USP 7% 0487-9007-302024-03-07
NEPHRON PHARMACEUTICALS
 Sodium Chloride Inhalation Solution, USP 3% 0487-9003-302024-03-07

Similar & Related FDA Registered Companies

Related Finance Registrations
U.S. Import Records [external site]
Import IDShipmentCargo DescriptionQuantity
201904179899Liverpool,United Kingdom -> New York/Newark Area, Newark, New JerseyLABELLING MACHINERY1 CAS
2019033032561Liverpool,United Kingdom -> New York/Newark Area, Newark, New JerseyLABELLING MACHINERY1 CAS
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.